Cigna Group(CI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 5:05 PM ET (Korea 10/28 06:05)
Full metrics table
| Index | S&P 500 | P/E | 12.34 | EPS (ttm) | 24.18 | Insider Own | 1.5% | Shs Outstand | 263.7M | Perf Week | -2.71% |
| Market Cap | 78.82B | Forward P/E | 8.91 | EPS next Y | 9.73% | Insider Trans | -5.38% | Shs Float | 260.3M | Perf Month | 9.73% |
| Enterprise Value | - | PEG | 1.18 | EPS next Q | 7.52 | Inst Own | 92.91% | Short Float | 2.6% | Perf Quarter | 0.61% |
| Income | 6.42B | P/S | 0.28 | EPS this Y | 2.25% | Inst Trans | -0.24% | Short Ratio | 4.1 | Perf Half Y | 4.69% |
| Sales | 282.50B | P/B | 1.85 | EPS next 5Y | 7.57% | ROA | 4.27% | Short Interest | 6.76M | Perf YTD | 8.37% |
| Book/sh | 161.62 | P/C | - | EPS past 3/5Y | 1.18% -0.69% | ROE | 15.49% | 52W High | -5.69% ($316.27) | Perf Year | -3.53% |
| Cash/sh | - | P/FCF | 8.65 | Sales past 3/5Y | 15.15% 11.35% | ROIC | 8.95% | 52W Low | 24.54% ($239.51) | Perf 3Y | -1.64% |
| Dividend Est. | $6.2 (2.08%) | EV/EBITDA | - | EPS Y/Y TTM | 31.47% | Gross Margin | - | Volatility(W/M) | 2.47% 2.69% | Perf 5Y | 39.78% |
| Dividend TTM | 6.19 | EV/Sales | - | Sales Y/Y TTM | 8.15% | Oper. Margin | 3.86% | ATR (14) | 7.73 | Perf 10Y | 142.39% |
| Dividend Ex-Date | 2026/9/8 | Quick Ratio | - | EPS Q/Q | 10.08% | Profit Margin | 2.27% | RSI (14) | 56.14 | Recom | 1.79 |
| Dividend Gr. 3/5Y | 10.47% 172.77% | Current Ratio | 0.85 | Sales Q/Q | 6.5% | SMA20 | 3.02% ($289.54) | Beta | 0.27 | Target Price | $342.09 |
| Payout | 27.23% | Debt/Eq | 0.75 | Earnings | 2026/11/5 | SMA50 | 5.52% ($282.68) | Rel Volume | 0.81 | Prev Close | $305.78 |
| Employees | 67700 | LT Debt/Eq | 0.68 | EPS/Sales Surpr. | 2.42% 2.17% | SMA200 | 6.04% ($281.29) | Avg Volume(3M) | 1.65M | Price | $298.28 |
| IPO | 1979/5/16 | Option/Short | Yes/Yes | Trades | 21897 | Volume | 1,339,871 | Change | -2.45% |
A leading global healthcare services company that integrates U.S. health insurance with pharmacy benefit management (including specialty pharmacy). Founded in 1792 with origins in the insurance business and headquartered in the United States, it has established itself as a key player in the U.S. health insurance and pharmacy benefit management market.
Over the past 1 year, on the higher side
6% below its 1-year high.
Traded about as much as usual. That is 81% of its average volume.
Next earnings report: November 5
9 days to go.
CI has weak earning power
Of every $100 in sales, $3.86 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +2.3% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company expected to earn $100 next year, you would pay $891. Peers typically go for $1,774. Compared with its own 5-year average, it is 15% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +39.8%. The S&P 500 did +70% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 2.08% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 92.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
GQGU GQG US Equity ETF 0.04% 
IHF iShares U.S. Healthcare Providers ETF 0.04% 
MDPL Monarch Dividend Plus Index ETF 0.03% 
DUSA Davis Select U.S. Equity ETF 0.03% 
VSMV VictoryShares US Multi-Factor Minimum Volatility ETF 0.03% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
VCIT Vanguard Intermediate-Term Corporate Bond ETF 67.1B 
IAU iShares Gold Trust 59.9B 
MUB iShares National Muni Bond ETF 54.1B 
VTEB Vanguard Tax-Exempt Bond ETF 52.4B 
XLF State Street Financial Select Sector SPDR ETF 51.5B It ranks #4 of 11 in the industry
Based on market cap of $79B.
CVS#2 CVS Health Corp $117B PER 24.1 
ELV#3 Elevance Health Inc $91B PER 18.0 
CI#4 Cigna Group $79B PER 12.3 
HUM#5 Humana Inc $50B PER 39.3 
CNC#6 Centene Corp $34B PER - 
Earnings Analysis · 7/30 Cigna Group ($CI) Q2 2026 Earnings Analysis — Adjusted EPS and Revenue Both Top Estimates, Full-Year Guidance Edged Up Investing Guides · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats Investing Guides · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is CI?
CI belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of CI?
The market cap of CI is approximately $78.8B, ranking 219 within its sector.
Does CI pay dividends?
CI has a dividend yield of approximately 2.08%, with an annual dividend of $6.20.
What is the P/E ratio of CI?
CI has a P/E ratio of approximately 12.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CI?
CI has recorded a 52-week high of $316.27 and a low of $239.51.
